LINC00520 and central nervous system cancer: In gliomas, TFAP4-66aa-uORF inhibits the TFAP4/LINC00520/miR-520f-3p feedback loop by directly inhibiting TFAP4 expression, thereby attenuating glioma malignancies (9).